Burnett Patrick — SEC Form 4 filings

SEC reporting owner CIK 1741987. 32 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2024-01-17 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcutis Biotherapeutics, Inc. (ARQT)See Remarks3244 legs · 405,508 sh · $5,765,48941

Form 4 filings — Burnett Patrick

FiledFormIssuerReported transactionsSource
2026-08-214Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,697 @ $27EDGAR
2026-08-134Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 8,300 @ $3.64 · Sale (S): 8,300 @ $26.52 · Option exercise (M): 6,700 @ $3.64 · Sale (S): 6,700 @ $26.08 · Option exercise (M): 8,300 (derivative) @ $0 · Option exercise (M): 6,700 (derivative) @ $0EDGAR
2026-08-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 955 @ $26.12EDGAR
2026-05-134Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 222 @ $21.05EDGAR
2026-05-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 684 @ $23.61EDGAR
2026-03-034Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 16,750 @ $0 · Grant/award (A): 30,000 @ $0 · Sale (S): 6,106 @ $25.16 · Sale (S): 181 @ $25.91 · Grant/award (A): 77,000 (derivative) @ $0EDGAR
2026-02-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 3,675 @ $25.50 · Sale (S): 9,794 @ $25.81EDGAR
2026-01-074Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,490 @ $28.98EDGAR
2026-01-024Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 541 @ $28.81 · Sale (S): 1,156 @ $29.39EDGAR
2025-12-174Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 11,500 @ $3.64 · Sale (S): 11,500 @ $28.94 · Option exercise (M): 11,500 (derivative) @ $0EDGAR
2025-11-104Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 17,250 @ $3.64 · Sale (S): 17,250 @ $24.18 · Option exercise (M): 17,250 (derivative) @ $0EDGAR
2025-11-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,607 @ $24.71 · Sale (S): 15 @ $25.40 · Sale (S): 3,864 @ $23.72EDGAR
2025-08-214Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,750 @ $16.16 · Sale (S): 2,438 @ $15.57EDGAR
2025-08-124Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 3,847 @ $14.03EDGAR
2025-08-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,622 @ $14.33EDGAR
2025-07-144Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 23,000 @ $0 · Sale (S): 23,000 @ $15.05 · Option exercise (M): 5,750 @ $0 · Sale (S): 5,750 @ $15.07 · Option exercise (M): 23,000 (derivative) @ $0 · Option exercise (M): 5,750 (derivative) @ $0EDGAR
2025-05-094Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 3,871 @ $13.59EDGAR
2025-05-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,597 @ $15.19EDGAR
2025-03-174Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 44,153 @ $14.97 · Option exercise (M): 5,008 @ $0 · Sale (S): 5,008 @ $15.10 · Option exercise (M): 12,242 @ $0 · Sale (S): 12,242 @ $15.04 · Option exercise (M): 5,008 (derivative) @ $0 · +1 moreEDGAR
2025-03-044Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 38,000 @ $0 · Grant/award (A): 17,000 @ $0 · Sale (S): 2,819 @ $13.03 · Sale (S): 954 @ $13.28 · Grant/award (A): 99,000 (derivative) @ $0 · Grant/award (A): 43,000 (derivative) @ $0EDGAR
2025-02-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 12,116 @ $12.70EDGAR
2024-12-314Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,691 @ $14EDGAR
2024-11-264Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 16,023 @ $0 · Sale (S): 16,023 @ $10.14 · Option exercise (M): 16,023 (derivative) @ $0EDGAR
2024-11-184Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 50,749 @ $10.29 · Option exercise (M): 18,377 @ $0 · Sale (S): 18,377 @ $10.29 · Option exercise (M): 100 @ $0 · Sale (S): 100 @ $10.03 · Option exercise (M): 18,377 (derivative) @ $0 · +1 moreEDGAR
2024-11-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 15,441 @ $8.68EDGAR
2024-08-214Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,728 @ $8.29EDGAR
2024-08-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 13,206 @ $9.02EDGAR
2024-05-314Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 49,952 @ $8.72 · Option exercise (M): 23,000 @ $0 · Sale (S): 23,000 @ $8.75 · Option exercise (M): 23,000 (derivative) @ $0EDGAR
2024-05-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 9,555 @ $8.74EDGAR
2024-03-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 4,782 @ $11.12EDGAR
2024-02-154Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 128,000 · Grant/award (A): 9,600 · Grant/award (A): 23,550 · Grant/award (A): 27,900 · Disposition to issuer (D): 320,000 (derivative) · Disposition to issuer (D): 28,800 (derivative) · +2 moreEDGAR
2024-01-174Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 28,000 @ $0 · Grant/award (A): 276,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741987 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →